Changmao Biochemical Engineering (HKG:0954) reported 25.8 million yuan in attributable loss for the half ended June 30, widening from 18.8 million yuan a year earlier, according to a Hong Kong bourse filing Monday.
Loss per share was 0.049 yuan, compared with 0.035 in the prior year.
Revenue fell 13% year-on-year to 272.3 million yuan, figures showed.